Protective long-term humoral immunity against pathogens depends on the generation of antibodies of high affinity that are capable of appropriate effector functions, a process which relies on the formation of germinal centers (GCs) in LNs or in the spleen during infection. GCs are essential but transient structures in which high affinity antibody-secreting cells and memory B cells are generated during a T cell--dependent (TD) antibody response. Although B cells constitute the majority of cells within a GC, macrophages, follicular DCs, and CD4^+^ T cells contribute to the defined architecture and the functionality of a GC during an immune response. These cells cooperate via antigen presentation, adhesion molecules, cell surface co-stimulatory molecules, and secreted factors to enable a robust GC reaction and an effective antibody response.

The formation and maintenance of GCs require a specialized subset of CD4^+^ T cells, T follicular helper cells (T~FH~ cells; [@bib83]; [@bib21]; [@bib55]). T~FH~ cells that are induced during TD responses are characterized by the expression of several critical surface markers that interact with ligands on APCs such as DCs and B cells. These molecules include co-stimulatory molecules and their ligands (PD-1, ICOS, CD200, OX40, and CD40-ligand), adhesion mediators of the Slam/SAP family, and receptors for IL-6 and IL-21 ([@bib41]; [@bib53]; [@bib49]; [@bib85]).

The coordinated induction of the chemokine receptor CXCR5, and repression of CCR7, allows T~FH~ to home to B cell follicles ([@bib1]; [@bib36]). CXCR5 induction depends on an OX40-mediated signal in T~FH~ ([@bib10]). Antigen-presenting B cells meet their cognate T~FH~ cells at the T--B border and engage in prolonged interactions, mediated by antigen and Slam/SAP proteins, to deliver signals that are essential for T~FH~ maintenance and subsequent productive GC formation ([@bib61]; [@bib23]). Once in the follicle, T~FH~ cells provide help to activated B cells through the expression of molecules such as CD40-ligand and ICOS and through the secretion of cytokines, predominantly IL-4 and IL-21 ([@bib16]; [@bib64]). IL-21, a pleiotropic cytokine, is a hallmark of T~FH~ cells. It has been shown to induce proliferation and expression of *Blimp1* and *Bcl6* in B cells, thereby influencing their decision to differentiate into antibody-secreting cells or to continue to participate in the GC reaction ([@bib57]; [@bib2]). Furthermore, IL-21 promotes switching to IgG~1~, IgG~2a~ and IgG~3~ and inhibits IgE responses ([@bib56]).

Recent studies have suggested that both IL-6 and IL-21 have pivotal roles in vivo in the generation of IL-21--secreting T~FH~ cells and the formation of GCs ([@bib41]; [@bib53]; [@bib76]). Differentiation of an activated CD4^+^ T cell into an IL-21--secreting T~FH~ cell is dependent on the transcription factor Bcl6, which acts as a master regulator for CD4^+^ T~FH~ cell differentiation ([@bib37]; [@bib54]; [@bib84]). In vitro, IL-6 and IL-21 are able to stimulate *Bcl6* and enhance *Il21* expression in CD4^+^ T cells, consistent with these cytokines serving an inductive role for T~FH~ ([@bib76]). [@bib53] reported that mice deficient in IL-6 formed fewer GC B cells and have reduced T~FH~ cell numbers after an immune challenge with sheep red blood cells. Similarly, other groups demonstrated a reduced frequency and size of GCs in IL-6--deficient mice ([@bib44]; [@bib81]). In some of the aforementioned studies, the impaired formation of GCs in the IL-6--deficient mice was linked to a reduction of IL-21--producing T~FH~ cells ([@bib53]; [@bib76]). IL-21 has also been implicated in the generation and maintenance of T~FH~ cells and the formation of GCs in vivo ([@bib53]; [@bib80]). Thus, it was proposed that IL-6 initially induces *Bcl6* and *Il21* expression in activated CD4^+^ T cells, and subsequently, IL-21 acts as a positive feedback loop to maintain *Il21* and *Bcl6* expression in the T~FH~ ([@bib54]; [@bib47]).

However, other studies have yielded conflicting results on the roles of IL-6 and IL-21 in T~FH~ cell generation and GC formation. These studies indicate that IL-21 is not essential for the generation of T~FH~ cells ([@bib47]; [@bib88]; [@bib63]) and that loss of IL-21R had little effect on initial GC development but was critical for GC maintenance during an immune response ([@bib47]; [@bib88]). Another study suggested that IL-6 was not required for the formation of T~FH~ cells or the GC response ([@bib60]). Both IL-6 and IL-21 signal predominantly through the same intracellular signal transducer, Stat3 ([@bib87]; [@bib53]; [@bib26]). Given the conflicting data and potential redundancy caused by a shared signaling pathway, we wished to test whether IL-6 and IL-21 could be functionally redundant in the TD antibody response to infection. We show here that the loss of either IL-6 or IL-21 alone has little effect on the development of GCs and the formation of T~FH~ cells in response to an acute viral infection. However, combined loss of both factors severely crippled the humoral immune response, including the development of GC B cells and the formation of T~FH~ cells. We further show that IL-6 and IL-21 act with different kinetics during the GC response and that B cells, in an Oct2/OBF-1--dependent manner, can supply the IL-6 necessary for early induction of T~FH~ development.

RESULTS
=======

Combined loss of IL-6 and IL-21 compromises GC formation
--------------------------------------------------------

Several studies examining the importance of either IL-6 or IL-21 in the formation and maintenance of GCs reported conflicting results ([@bib44]; [@bib56]; [@bib53]; [@bib80]; [@bib81]; [@bib60]; [@bib47]; [@bib88]; [@bib63]). Many of these investigators variously used immunization with either hapten antigens or sheep red blood cells as the experimental model. We wished to assess the roles of IL-6 and IL-21, individually or in combination, in the formation of GCs and T~FH~ cells in a physiological model of acute viral infection.

WT C57BL/6 or IL-6--, IL-21--, or IL-21R--deficient mice were infected intranasally with the HKx31 strain of influenza virus. GC B cells (B220^+^, Fas^+^, PNA^+^) in the lung-draining mediastinal LNs (mLNs) and the spleens of infected mice were assessed by flow cytometry at days 10 and 21 after infection. Individual loss of IL-6 or IL-21 had little impact on GC B cells in the draining LNs in this infection model ([Fig. 1, A and B](#fig1){ref-type="fig"}). In the spleen on day 10 after infection, neither IL-21-- nor IL-6--deficient mice showed a significant difference of GC B cells compared with WT ([Fig. 1 C](#fig1){ref-type="fig"}). Similar results were observed when measuring GC B cells in mLNs and spleen on day 21 after infection in IL-6-- or IL-21R--deficient mice ([Fig. 1, E and F](#fig1){ref-type="fig"}). Because IL-6 and IL-21 signal through a common transducer, Stat3, it was possible that they play redundant roles in the generation of GCs during an acute viral infection. To test this possibility, IL-6/IL-21 compound mutant mice (DKO) were generated and infected with influenza virus. 10 d after infection, GC formation was assessed and compared with WT and single mutant mice. IL-6/IL-21 DKO mice showed a significant reduction in GCs in both the draining LNs and the spleens on day 10, at the peak of the immune response ([Fig. 1, A--D](#fig1){ref-type="fig"}; [@bib31]), and this was even more pronounced at day 21 after infection ([Fig. 1, E and F](#fig1){ref-type="fig"}). The GC deficit in infected DKO mice was confirmed through immunohistochemical staining of spleen sections ([Fig. 1, D and G](#fig1){ref-type="fig"}), which showed significantly reduced GC B cell areas in the spleens of DKO mice compared with controls. These results indicate that IL-6 and IL-21 in combination play an essential role in the development of GC B cells in response to acute viral infection.

![**Combined loss of IL-6 and IL-21 compromises GC formation in influenza infection.** Analysis of GC B cells in C57BL/6 (WT), IL-6, IL-21, and IL-6/IL-21 double-deficient mice (DKO). Mice were analyzed on day 10 after influenza infection. Results shown are from three to six independent experiments, totaling 4 naive WT and 21 WT, 8 *Il6^−/−^*, 8 *Il21^−/−^*, and 16 DKO-infected mice, respectively. (A) Cells from the draining mLNs and from the spleen were stained for GC B cells with α-B220, α-Fas, and PNA, and the percentage of B220^+^ cells that were also PNA^+^/Fas^+^ is shown. (B and C) Frequency distribution of GC B cells in spleens and mLNs from WT and mutant mice analyzed on day 10 of infection. (D) Ratio of GC area to B cell follicle area in spleens of WT and DKO animals on day 10, as measured from histological sections. Each symbol represents an individual animal. (E and F) Frequency distribution of GC B cells from WT and mutant mice analyzed on day 21 of infection. Each symbol represents an individual animal. Statistical analyses used Tukey's multiple comparison tests. \*\*\*, P \< 0.001; \*\*, P = 0.001--0.001; \*, P = 0.01--0.05. Bars and numbers show mean percentage with ± SEM. Results are from three to six independent experiments. (G) Representative histological staining to detect GCs in spleens from control or mutant mice 10 d after influenza infection. Paraffin sections were stained with α-GL7, α-B220, and α-CD3. Bars, 50 µm.](JEM_20111504_Fig1){#fig1}

As IL-21 has been shown to contribute to CD8^+^ T cell responses ([@bib13]; [@bib52]), we wanted to ensure that the defective GC development we observed in the double mutants was not influenced by a crippled CD8^+^ response to the influenza infection. We therefore measured virus-specific CD8^+^ T cell responses in WT and DKO mice during the peak of the immune response. There was no significant difference in the frequency of virus-specific CD8^+^ T cells between WT and mutant mice ([Fig. 2 A](#fig2){ref-type="fig"}). Furthermore, there was no difference in the percentage of mature effector KLRG1^+^CD44^+^CD8^+^ T cells in control and DKO mice ([Fig. 2 B](#fig2){ref-type="fig"}), demonstrating that, unlike the GC response, the antiviral CD8^+^ T cell response was unaffected by the loss of these two cytokines.

![**Combined loss of IL-6 and IL-21 does not affect the virus-specific CD8 response but limits T~FH~ formation and the antibody response in influenza infection.** Analysis of anti-influenza CD8 responses in WT and DKO animals. Mice were analyzed on day 10 after infection. (A) Splenocytes and cells from the bronchoalveolar lavage (BAL) were stained with α-CD8, α-CD44, and either NP-tetramer or PA-tetramer. Frequency distribution of splenic, virus-specific CD8^+^ T cells (tetramer stains: NP, black symbols; PA, gray symbols) is shown in a representative of two independent experiments using three to five animals of each genotype. (B) Frequency distribution of KLRG1/CD44 double-positive CD8^+^ T cells in spleen and bronchoalveolar lavage. Each symbol represents an individual animal. Bars and numbers show mean percentage with ± SEM. (C) WT, IL-6-- or IL-21--deficient, and DKO mice were infected with HKx31 influenza virus and analyzed on day 10 after infection. Cells from the mLNs were stained for T~FH~ cells with α-CD4, α-CXCR5, and α--PD-1, and the percentage of PD-1/CXCR5 double-positive CD4^+^ T cells was measured. (D) Frequency of T~FH~ from WT and mutant mice analyzed on day 10 after infection. Representative example shown of two to six independent experiments, totaling 6 naive WT, 23 WT, 8 *Il6^−/−^*, 8 *Il21^−/−^*, and 19 DKO-infected mice, respectively. (E) CD4^+^PD-1^+^CXCR5^+^ T~FH~ cells and CD4^+^PD-1^−^CXCR5^−^ T cells were sorted from spleen on day 14 of HKx31 influenza infection. *Bcl6* and *Il21* expression was measured by RT-qPCR. (As expected, *Il21* is not expressed in the DKO mice. This is a control only.) Bars and numbers show relative gene expression normalized to the housekeeping gene, *Hmbs*, ± SEM (*n* = 3). (F) IL-21--GFP reporter mice, on a WT or *Il6^−/−^* background, were infected, and mLNs were harvested on days 6, 8, and 10 and stained for T~FH~ cells (CD4, TCR-β, CXCR5, and PD-1). The dot plot shows IL-21--expressing cells in the CD4^+^/TCR-β^+^ gate on day 10. (G) Time course showing total numbers of IL-21--expressing T~FH~ in the draining mLNs from days 6 to 10 of infection. Numbers show means ± SEM of five animals in each group. IL-21/GFP^+^ cells were also CD4^+^, TCR-β^+^, PD-1^+^, CXCR5^+^. (H) IgM and IgG HKx31-specific responses in WT, IL-6, IL-21R, and DKO mice. Serum IgM and IgG titers were measured by ELISA on day 14 of the influenza infection and are represented as the reciprocal of serum dilutions, giving an absorbance that was 50% of maximum value for the assay. Each symbol represents an individual animal. \*\*\*, P \< 0.001; \*\*, P = 0.001--0.001; \*, P = 0.01--0.05. Bars and numbers show mean dilution ± SEM.](JEM_20111504_Fig2){#fig2}

The combined actions of IL-6 and IL-21 control the early generation of T~FH~ cells
----------------------------------------------------------------------------------

The defective GC reaction in DKO mice raised the question of whether the relevant T helper cell response in these mice was impaired. We examined the draining LNs 10 d after influenza infection from WT, IL-6 and IL-21 singly deficient mice, and DKO mice for CD4^+^ T cells expressing the T~FH~ markers CXCR5 and PD-1 ([@bib79]). Infected, but not naive, WT mice showed a distinct T~FH~ cell population in the draining LNs. Loss of IL-6 or IL-21 alone did not cause a significant change in frequency of T~FH~ cells ([Fig. 2, C and D](#fig2){ref-type="fig"}). However, there was a significant reduction of T~FH~ cells at day 10 of the infection in DKO mice. Interestingly, by day 21, T~FH~ frequencies were similar in all mice (not depicted), implying that IL-6 and IL-21 affect most strongly the early stages of T~FH~ development.

Both IL-6 and IL-21 have been implicated in the induction of *Bcl6* and *Il21* expression ([@bib54]; [@bib47]), hallmarks of T~FH~ cells. We therefore assessed whether T~FH~ cells that develop in the absence of IL-6 and IL-21 expressed *Bcl6*. To that end, we isolated CD4^+^PD-1^+^CXCR5^+^ T~FH~ and CD4^+^PD-1^−^CXCR5^−^ non-T~FH~ cells from influenza-infected WT and DKO mice and measured *Bcl6* and *Il21* messenger RNA (mRNA) expression ex vivo by real-time quantitative PCR (qPCR). The combined loss of IL-6 and IL-21 did not alter *Bcl6* expression in the T~FH~ cells ([Fig. 2 E](#fig2){ref-type="fig"}). These results indicate that IL-6 and IL-21 play critical but redundant or complementary roles early during T~FH~ cell generation or expansion, but T~FH~ cells formed in their absence are normal.

Because in an earlier study ([@bib88]) we showed that loss of IL-21 or its receptor did not change the kinetics of T~FH~ appearance after immunization, we focused on the influence of IL-6. To explore the rate of induction of T~FH~ in vivo, we made use of our recently described IL-21--GFP knockin reporter mice ([@bib48]). In these mice (which are heterozygous for a functional *Il21* allele), IL-21--GFP^+^ CD4 cells can be clearly visualized as a subset of T~FH~ cells that localize to the GCs during infection or immunization and express cytokine genes as well as the T~FH~ hallmarks PD-1, CXCR5, and Bcl6. We enumerated CD4^+^/GFP^+^ cells in WT and *Il6^−/−^* mice bearing the IL-21--GFP allele ([Fig. 2 F](#fig2){ref-type="fig"}) during the early stages of the antiviral response (days 6--10; IL-21--GFP^+^ cells only appear after day 5 in this model; unpublished data) and found that T~FH~ cells in *Il6^−/−^* mice were significantly delayed in their generation, but nearly matched WT numbers by day 10 in the mLNs ([Fig. 2 G](#fig2){ref-type="fig"}). As expected, GC B cells followed similar kinetics with *Il6^−/−^* mice, trailing their WT counterparts (not depicted). These data show that IL-6 strongly influences T~FH~ induction or expansion early in the antiviral response.

Collectively, these data concur with previous studies showing that neither IL-6 nor IL-21 alone is required for the generation of GCs or T~FH~ cells ([@bib60]; [@bib47]; [@bib88]; [@bib63]). However, we show here that the simultaneous loss of both cytokines strongly blunts both GC and T~FH~ development. IL-6 deficiency significantly delays T~FH~ induction in vivo. Thus, the highly interdependent T~FH~ and GC B cell response to infection relies on the combined actions of IL-6 and IL-21

IL-6 and IL-21 are critical for an effective antibody response to acute viral infection
---------------------------------------------------------------------------------------

To assess the consequences of the impaired T~FH~ and GC development in IL-6/IL-21 DKO mice on the humoral antiviral response, we measured antiviral IgM and IgG levels in the serum of WT, single mutant, and DKO mice on day 14 of the infection. Although the single loss of IL-6 or IL-21R alone (which phenocopies loss of IL-21 in the antibody response; [@bib88]) had no impact on the IgM response and only a modest impact on IgG titers, combined loss of IL-6 and IL-21 resulted in a significant (approximately threefold) reduction in virus-specific IgM ([Fig. 2 H](#fig2){ref-type="fig"}). IL-21R--deficient mice had an impaired IgG response (∼3-4-fold), but the combined absence of IL-21 and IL-6 magnified this effect, reducing IgG titers to ∼14-fold lower than in WT mice ([Fig. 2 H](#fig2){ref-type="fig"}), confirming that the combined actions of IL-6 and IL-21 are essential for a strong humoral response to acute viral infection.

IL-6 is induced early in B cells during an immune reaction
----------------------------------------------------------

Although the combined loss of IL-6 and IL-21 impaired the formation of T~FH~ cells and strongly reduced the GC response, the maintenance of T~FH~ cells was independent of IL-6 and IL-21. We therefore reasoned that these cytokines play important roles early in a viral infection, during the initiation of T~FH~ cell differentiation. To test whether the kinetics of expression of both cytokines was compatible with this prediction, we measured *Il6* and *Il21* mRNA levels in cells from the draining mLNs at different time points after influenza infection in WT mice. The expression of *Il21* in CD4^+^ cells in the draining LNs stayed low early in the infection, reaching appreciable levels on days 3--5, which were sustained until at least day 10 ([Fig. 3 A](#fig3){ref-type="fig"}). In contrast, *Il6* mRNA was transiently expressed in CD19^+^ B cells, rising sharply between days 1 and 2 of infection, peaking at days 2--3 and falling by day 5 ([Fig. 3 A](#fig3){ref-type="fig"}). Although APCs such as DCs and macrophages are thought to be a source of IL-6 in the early process of T~FH~ priming ([@bib44]; [@bib22]), our data show that B cells also secrete IL-6 early after an acute viral infection ([Fig. 3 A](#fig3){ref-type="fig"}). To test whether IL-6 expression was restricted to newly activated cells, we isolated activated (CD86^+^CD69^+^) and resting (CD86^−^CD69^−^) B cells (CD19^+^CD11c^−^CD11b^−^) from the draining LNs of mice 3 d after infection and from naive controls. Among B cells, *Il6* mRNA was restricted to the activated cell compartment in the infected mice ([Fig. 3 B](#fig3){ref-type="fig"}), indicating that activated B cells represent a rapid and abundant cellular source of IL-6 after infection. Furthermore, activated B cells increased rapidly and dramatically in number to become the most abundant APC in the draining mLNs between days 2 and 10 of infection ([Fig. 3 C](#fig3){ref-type="fig"}).

![**IL-6 and IL-21 are expressed early during an influenza infection.** (A) CD4^+^ and CD19^+^ cells were isolated from mLNs on the indicated days after influenza infection. *Il21* or *Il6* mRNA expression was measured by qPCR. (B) Cells from the mLNs of naive and infected animals were stained with α-CD19, α-CD11c, α-CD11b, α-CD69, and α-CD86. Resting (G1) and activated follicular B cells (G2) were sorted. Bars and numbers show relative *Il6* expression normalized to *Hmbs* ± SEM (*n* = 3) in each sorted population. (C) Time course of total cell numbers of activated and GC B cells, DCs, and macrophages in mLNs of infected mice. Numbers are means ± SEM of five mice. (D) Co-culture of WT naive CD62L^+^/CD4^+^ T cells, stimulated with α-CD3/α-CD28, and different numbers of CpG-preactivated B cells from control or IL-6--deficient mice. The left panel shows CD3/CD28-activated T cells with medium alone or with recombinant IL-6. After 4 d of co-culture, the CD4^+^ T cells were sorted, and *Il21* mRNA expression was determined. The results are representative of three independent experiments. (A and D) Error bars represent SDs of triplicate assays. (E and F) WT, congenic Ly5.1^+^ B cells were injected into WT and DKO animals 2 d before influenza infection. 10 d after infection, cells from the mLNs were stained for T~FH~ and GC B cells as described for [Figs. 2 C](#fig2){ref-type="fig"} and [1 A](#fig1){ref-type="fig"}, respectively. Figures show fold change of each animal's T~FH~ or GC B cells compared with the mean percentage of T~FH~ or GC B cells from controls within each experiment. Results are from three to six independent experiments. (E) T~FH~ ratio comparing WT and DKO animals without or with rescue by WT Ly5.1 B cells. (F) GC B cell ratio comparing WT and DKO animals without or with rescue by WT Ly5.1 B cells. Each symbol represents an individual animal. Statistical analyses were performed using the two-sample Wilcoxon test, and all p-values are two-sided. Bars and numbers show fold change ± SEM.](JEM_20111504_Fig3){#fig3}

Next, we wished to determine whether IL-6 produced by activated B cells was sufficient to induce the generation of IL-21--producing CD4^+^ T cells in vitro. B cells were stimulated for 24 h with CpG1668, a known inducer of IL-6 production by B cells ([@bib82]). They were then added, at different cell ratios, to cultures of α-CD3/α-CD28--stimulated naive CD4^+^ T cells. After 4 d, the CD4^+^ T cells were recovered and assayed for *Il21* expression. In control cultures, and consistent with published results ([@bib25]), CD4^+^ T cell activation in the presence of soluble recombinant IL-6 induced marked *Il21* expression ([Fig. 3 D](#fig3){ref-type="fig"}). *Il21* was also strongly induced in activated T cells that were co-cultured with equal numbers of CpG-activated WT B cells, and the amount of *Il21* mRNA expressed in the CD4^+^ T cells was proportional to the number of B cells added to the cultures. IL-6--deficient B cells failed to induce *Il21* mRNA expression in co-cultured CD4^+^ T cells ([Fig. 3 D](#fig3){ref-type="fig"}), indicating that B cell--derived IL-6 is necessary and sufficient to induce IL-21 production by CD4^+^ T cells in this co-culture system.

Finally, we wished to determine whether B cell--derived IL-6 supported T~FH~ formation in vivo. To this end, 1--2 × 10^7^ IL-6--sufficient B cells from Ly5.1 congenic mice were injected on two consecutive days into either WT or DKO mice. The mice were then infected with influenza virus, and T~FH~ generation and GC B cell formation in the draining LNs were analyzed. B cell transfer was relatively inefficient, but by 10 d after infection, a small proportion of donor-derived B cells (≤6% of total B cells) were evident in each experiment (not depicted). As shown ([Figs. 2](#fig2){ref-type="fig"} and [3 E](#fig3){ref-type="fig"}), loss of IL-6 and IL-21 leads to a clear reduction of T~FH~. However, transfer of IL-6--sufficient B cells led to a significant rescue of the T~FH~ population in DKO mice ([Fig. 3 E](#fig3){ref-type="fig"}). In parallel, we observed a partial but significant rescue of GC formation in DKO mice that had received IL-6--sufficient B cells ([Fig. 3 F](#fig3){ref-type="fig"}). The rescue was notable considering the low ratio of IL-6--sufficient to --deficient B cells in the recipients. Collectively, these data show that IL-6 is expressed by activated follicular B cells in the draining LNs early after viral infection (days 2--3) and that IL-6 supplied by activated B cells is sufficient to drive IL-21 expression in CD4^+^ T cells in vitro and T~FH~ cell development in vivo.

Oct2- and OBF-1--deficient B cells are impaired in IL-6 production
------------------------------------------------------------------

The factors that influence IL-6 production during T~FH~ expansion and GC formation are largely unknown. We focused our attention on Oct2 (a DNA-binding POU/homeodomain transcriptional activator) and OBF-1 (OCA-B/Bob.1), a coactivator for Oct1 and Oct2 ([@bib34]; [@bib46]), because our own studies on TLR signaling responses in B cell lines indicated that both Oct2- and OBF-1--deficient cells expressed less *Il6* than controls (unpublished data), and a recent publication suggested that octamer-binding transcription factors are involved in the transcriptional regulation of the human *IL6* gene ([@bib73]).

We therefore examined whether loss of OBF-1 or Oct2 has an effect on *Il6* expression in primary B cells. OBF-1 expression is restricted to the lymphocyte compartment of the immune system. Consistent with the lack of OBF-1 expression in myeloid cells, OBF-1 loss had no impact on *Il6* expression in macrophages (CD11b^+^/GR1^+^) or BM-derived DCs stimulated with LPS or CpG ([Fig. 4, A and B](#fig4){ref-type="fig"}). In contrast, *Il6* expression in B cells was strongly influenced by the loss of OBF-1 or Oct2. B cells up-regulate Oct2 and OBF-1 upon activation ([Fig. 4 C](#fig4){ref-type="fig"}). Splenic B cells purified from WT and Oct2- and OBF-1--deficient mice were cultured with various mitogens, and *Il6* expression was measured by qPCR. Although *Il6* expression was induced under all conditions (and most strongly by TLR ligands) in WT B cells, its induction was very weak in both Oct2- and OBF-1--deficient B cells, especially in LPS or CpG cultures ([Fig. 4, D and E](#fig4){ref-type="fig"}). Consistent with these results, CpG-activated Oct2- or OBF-1--deficient B cells were strongly impaired in their capacity to induce *Il21* transcription in co-cultured CD4^+^ T cells, most clearly seen when their numbers were limiting ([Fig. 4 F](#fig4){ref-type="fig"}). Addition of exogenous IL-6 to these co-cultures fully complemented the deficiencies of Oct2, OBF-1, or IL-6 mutant B cells, inducing robust *Il21* mRNA expression in the responding CD4^+^ T cells ([Fig. 4 G](#fig4){ref-type="fig"}) and confirming that IL-6 is the dominant inductive cytokine in these cultures.

![**Induction of IL-6 in activated B cells is dependent on Oct2 and OBF-1.** (A and B) qPCR measurement of *Il6* expression in sorted and LPS- or CpG-stimulated Gr1^+^, Mac1^+^ macrophages or BM-derived DCs from WT or *Obf-1^−/−^* mice. (C) Western blot analysis of Oct2 and OBF-1 in mature resting or CpG- or LPS-stimulated B cells. Blots were probed with α--OBF-1, α-Oct2, or α-actin. (D and E) *Il6* expression in sorted and activated splenic B220^+^ B cells from OBF-1--deficient or WT mice and *Oct^+/+^* or *Oct^−/−^* B cells from fetal liver reconstituted mice. Bars and numbers show relative gene expression normalized to *Hmbs* expression ± SEM (*n* = 3). (F) In vitro generation of IL-21--producing cells. Co-culture of WT naive CD4^+^, CD62L^+^ T cells, activated with α-CD3/α-CD28, with different numbers of CpG-preactivated B cells from WT, *Obf-1^−/−^*, *Oct2^−/−^*, or IL-6--deficient mice. After 4 d of co-culture, the CD4^+^ T cells were sorted, and *Il21* expression was determined by qPCR. (A and F) Error bars represent SDs of triplicate assays. (G) T cells stimulated with medium alone, with recombinant IL-6, or with B cells and recombinant IL-6. *Il21* expression was determined by qPCR and normalized as described for D--E. Bars and numbers show relative gene expression normalized to *Hmbs* expression ± SEM (*n* = 3).](JEM_20111504_Fig4){#fig4}

Molecular regulation of the IL-6 locus by octamer-binding factors
-----------------------------------------------------------------

To investigate whether octamer-binding factors directly interact with the murine *Il6* locus control regions, we first analyzed the *Il6* gene for consensus octamer-binding sites. The *Il6* locus in mice spans a region of ∼7 kb on mouse chromosome 5. A previous study has identified binding sites for several transcription factors (AP-1, NF-κB, or CEBP family members) at a core promoter region ∼230 bp upstream of the transcription start site ([Fig. 5 A](#fig5){ref-type="fig"}; [@bib3]). Bioinformatics analysis using PROMO ([@bib50]) revealed four consensus octamer-binding sites within the *Il6* locus: octamer 1, ATTTGCAT −3309 to −3302; octamer 2, TTTTGCAT −1459 to −1452; octamer 3, ATTTGCAT 3793 to 3800; and octamer 4, ATTTGCAT 10615 to 10622 ([Fig. 5 A](#fig5){ref-type="fig"}).

![**Functional octamer factor binding sites in the *Il6* locus.** (A) Organization of the *Il6* locus and location of the core promoter region. Positions of four consensus octamer sites identified in silico are shown. AK039125 is an adjacent gene. (B) EMSA analysis on nuclear extracts from 24-h CpG-stimulated splenic B cells, performed using short fragments (160--207 bp) containing the consensus octamer site (ATGCAAT) from an Ig heavy chain promoter or octamer sequences identified in the *Il6* locus (site 1, ATTTGCAT −3302; site 2, TTTTGCAT −1438; site 3, ATTTGCAT 3793; site 4, ATTTGCAT 10615). Specific complex formation was detected through supershifts using α-Oct2 or α--OBF-1 monoclonal antibodies, as indicated. Oct2--DNA complexes are indicated with asterisks. The results are representative of three independent experiments. (C and D) Immunoprecipitation (ChIP) of chromatin from purified splenic B cells from mice of the indicated genotypes, using preimmune and hyperimmune rabbit serum specific for Oct2. (C) *Cd36* is a known Oct2 target gene ([@bib43]). (D) ChIP on the same chromatin as in C, but examining the octamer-containing *Il6* gene sequences identified in A and positive by EMSA (B). Values in all graphs are means ± SEM (*n* = 3).](JEM_20111504_Fig5){#fig5}

To determine whether the putative octamer-binding sites in the *Il6* gene are functional, nuclear extracts from CpG-stimulated B220^+^ B cells were used for electrophoretic mobility shift assays (EMSAs). Endogenous Oct2 bound to all four predicted octamer sites ([Fig. 5 B](#fig5){ref-type="fig"}). In accordance with earlier evidence and our unpublished data indicating that OBF-1 does not directly contact DNA but associates with DNA-bound Oct2 or Oct1 ([@bib75]), it was not possible to detect direct binding of OBF-1 to these octamer sites. Each of the sites, however, has the consensus sequence known to be necessary to recruit OBF-1 to the Oct--DNA complex ([@bib34]). Consistent with the EMSA results, chromatin immunoprecipitation (ChIP) revealed that Oct2 associates with all four sites in vivo ([Fig. 5 D](#fig5){ref-type="fig"}), as it does with the established Oct2 target gene, *Cd36* ([Fig. 5 C](#fig5){ref-type="fig"}; [@bib43]; [@bib71]). These data show that several sites in the *Il6* locus can be bound directly by Oct2 and suggest that OBF-1, in complex with Oct2, directly regulates *Il6* expression in B cells. Together these experiments show that *Il6* expression in B cells is strongly dependent on Oct2 and OBF-1.

Impaired T~FH~ cell development in OBF-1--deficient mice
--------------------------------------------------------

To determine whether OBF-1 or Oct2 is involved in GC and T~FH~ development in response to viral infection, WT and OBF-1-- or Oct2-deficient mice were infected with influenza virus. The formation of T~FH~ cells and GC B cells was assessed on day 10 after infection. Although Oct2-deficient mice showed normal development of GC B cells in infected mice (in contrast to a study using hapten protein immunization; [@bib70]), GC B cells were severely reduced or absent in the lung-draining LNs of OBF-1--deficient mice compared with WT ([Fig. 6, A and B](#fig6){ref-type="fig"}). OBF-1 KO mice also showed a significantly reduced T~FH~ cell compartment when compared with WT or *Oct2^−/−^* mice ([Fig. 6, C and D](#fig6){ref-type="fig"}). Consistent with these cellular deficiencies, virus-specific Ig was severely reduced in OBF-1--deficient mice (not depicted). Thus, optimal genesis of both GC B cells and T~FH~ cells is dependent on OBF-1 but not Oct2.

![**Loss of OBF-1 but not Oct2 results in loss of GCs and reduction of T~FH~ during influenza infection.** Analysis of GC B cells and T~FH~ cells in control or OBF-1-- or Oct2-deficient mice on day 10 of infection. (A and B) mLN cells were stained with α-B220, α-Fas, and PNA to detect GC B cells. Representative staining is shown in A, and summary of data for all mice is shown in B. (C and D) mLN cells were stained with α-CD4, α-CXCR5, and α--PD-1 to detect T~FH~ cells. Representative staining is shown in C, and the frequency distribution for all mice is shown in D. (E) Analysis of *Bcl6* and *Il21* expression in CD4^+^, PD-1^+^, and CXCR5^+^ T~FH~ sorted from spleens of WT and *Obf-1^−/−^* mice 10 d after influenza infection. Bars and numbers show mean normalized gene expression with ± SEM (*n* = 3). (F and G) T~FH~ and GC B cells were analyzed in WT:*CD19^−/−^*, *Obf-1^−/−^*:*CD19^−/−^*, WT:*TCRα^−/−^*, and *Obf-1^−/−^:TCRα^−/−^* mixed BM chimeras 10 d after influenza infection. (F) Cells from the mLNs were stained for GC B cells as described in A and B. (G) Cells from the mLNs were stained for T~FH~ cells, as described for E. Each symbol represents an individual animal. \*\*\*, P \< 0.001; \*, P = 0.01--0.05. Results are from three independent experiments.](JEM_20111504_Fig6){#fig6}

OBF-1 has been previously implicated in the differentiation of helper T cells ([@bib11]). Thus we asked whether T~FH~ cells of OBF-1--deficient mice show a normal functional phenotype in vivo and in vitro. First, we measured mRNA expression of the T~FH~ cytokine *Il21* and the T~FH~ cell regulator *Bcl6* in phenotypic T~FH~ cells sorted from WT and OBF-1--deficient mice. *Bcl6* and *Il21* mRNA expression was normal in T~FH~ cells from OBF-1 KO mice ([Fig. 6 E](#fig6){ref-type="fig"}). We then tested whether CD4^+^ T cells from OBF-1--deficient mice were able to differentiate into IL-21--producing cells T cells in vitro and found that WT and mutant T cells were equally capable of doing so (not depicted). Thus, once they are formed, T~FH~ cells in the *Obf1^−/−^* mice have a normal phenotype. This strongly suggests that reduced numbers of T~FH~ cells in the *Obf1^−/−^* mice are caused by a T cell--extrinsic defect. To test this, we generated mixed BM chimeras using BM from T cell--deficient or B cell--defective mice (*TCRα^−/−^* or *Cd19^−/−^*, respectively) and BM from OBF-1--deficient or control mice. 8 wk after reconstitution, the recipient mice were infected with influenza virus and analyzed 10 d later. In mice reconstituted with OBF-1--deficient T cells together with WT B cells, GC B and T~FH~ cells formed normally ([Fig. 6, F and G](#fig6){ref-type="fig"}), indicating that OBF-1--deficient T cells are not impaired in their ability to differentiate to T~FH~ and to provide sufficient help for GC B cell development in vivo. In contrast, mice with OBF-1--deficient B cells and WT T cells (*Obf1^−/−^:CD19^−/−^*) showed no GC and reduced T~FH~ cell generation, demonstrating that defective GC formation and reduced T~FH~ cell development are B cell intrinsic in *Obf-1^−/−^* mice.

DISCUSSION
==========

Initiation of a TD antibody response
------------------------------------

Very recently, the cellular, anatomical, and molecular events that occur during the earliest stages of a TD B cell response have been scrutinized by several groups (e.g., [@bib21]; [@bib24]; [@bib78]). Among their findings are the critical importance of antigen and DCs as early inducers of T~FH~ polarization in the T cell zone, the colocalization of T~FH~ with antigen-specific B cells, and the need for prolonged contact between T~FH~ precursors and cognate B cells ([@bib32]; [@bib36]; [@bib23]; [@bib60]; [@bib6]; [@bib15]; [@bib38]; [@bib42]). Prolonged B cell--T cell interaction is critical and is mediated by Slam/SAP family receptors, allowing the sustained antigen signal that apparently drives T~FH~ cell differentiation and maintenance ([@bib61]; [@bib12]). Once cognate T cells and B cells have been activated by antigen during an immune response to a pathogen, IL-6 is thought to drive T~FH~ cell differentiation and IL-21 secretion ([@bib30]; [@bib40]). Subsequently, during a B cell--T cell interaction in a GC, IL-21 can act on both the B cell, driving isotype switching and differentiation to an antibody-secreting plasma cell ([@bib45]; [@bib47]; [@bib88]), and in an autocrine fashion on the T~FH~ cell, reinforcing signals that maintain the T~FH~ phenotype ([@bib53]; [@bib80]). Here we show that, in addition to antigen and other co-stimulatory surface molecule interactions, B cells release IL-6 to promote T~FH~ in response to infection.

The role of IL-21 in GC formation and T~FH~ development
-------------------------------------------------------

Some uncertainty surrounds the role of IL-21 during TD B cell responses. Some studies described an impaired initial GC B cell response to various antigens in the absence of an IL-21 signal ([@bib53]; [@bib80]; [@bib8]; [@bib60]; [@bib29]; [@bib63]). In contrast, [@bib57] and [@bib88] did not detect early GC abnormalities upon loss of IL-21 or IL-21R but saw impaired persistence of GCs. Here we also found normal GC formation in IL-21-- or IL-21R--deficient mice on day 10 of an acute viral infection.

The influence of IL-21 on the formation and maintenance of T~FH~ in vivo is also unclear. Some studies describe a reduction of T~FH~ cells in the absence of IL-21 or IL-21R ([@bib53]; [@bib80]), whereas others suggest that IL-21 is specifically required for T~FH~ cell persistence but not formation ([@bib47]). Still others report no impact of IL-21 or IL-21R on the formation of T~FH~ cells ([@bib8]; [@bib60]; [@bib88]; [@bib29]; [@bib63]). We find here that loss of either IL-21 or IL-21R had little impact on T~FH~ formation during influenza infection at any time point examined.

The role of IL-6 in GC formation and T~FH~ development
------------------------------------------------------

Studies to define a role for the pleiotropic cytokine IL-6 in TD immune responses have also yielded conflicting results. [@bib44] demonstrated that IL-6--deficient mice had reduced serum IgG~2a~ and formed smaller GCs than controls upon DNP-OVA immunization, whereas others have demonstrated a more severe impact of IL-6 loss on the appearance of GC B cells ([@bib53]; [@bib81]). However, [@bib60] and [@bib29] saw no significant reduction of GC B cells after LCMV infection in mice deficient for IL-6 or after IL-6 neutralization. We also find here that loss of IL-6 caused only minimal reduction of GC B cells at the peak of an influenza infection and had a mild effect on GC maintenance.

Although the activity of IL-6 as an inducer of IL-21 expression in CD4^+^ T cell cultures is well established ([@bib76]; [@bib25]), its in vivo role in the generation of T~FH~ is not. [@bib53] showed that IL-6 loss caused a strong reduction of T~FH~ cells in response to sheep red blood cell immunization, conclusions which conflict with other studies ([@bib60]; [@bib15]). Our kinetic data suggest that IL-6 acts primarily in the induction and/or expansion of T~FH~ early in the immune response, as seen most clearly using the IL-21--GFP reporter system on an *Il6^−/−^* background, but that T~FH~ cell numbers normalize as the response proceeds ([Fig. 2](#fig2){ref-type="fig"}).

One explanation for the conflicting data regarding the roles of IL-6 and IL-21 in GC and T~FH~ responses is likely to be the variety of experimental systems used, including immunization with synthetic or nonreplicating antigens (hapten-coupled proteins or sheep red blood cells), or infectious agents, and the differing levels of inflammation (and so IL-6 production) that might result in each situation. Another may be that IL-6 and IL-21 act cooperatively, and loss of either factor alone can be compensated in vivo. The latter is consistent with the results presented here analyzing IL-6/IL-21 double-deficient mice, which clearly show that IL-6 and IL-21 act together on the formation, persistence, and function of GCs and T~FH~ cells. Our findings disagree with aspects of a recent study ([@bib29]), which showed that IL-6 neutralizing antibody had no additional impact on GC formation over IL-21 loss alone. It is possible that IL-6 neutralizing antibody cannot fully neutralize all IL-6 in vivo (particularly if the IL-6 is delivered within a tight junction from cognate B cell to T~FH~ cell), leading to an underestimation of its contribution to the response. Nevertheless, we concur with the general conclusion of this paper, that IL-6 and IL-21 serve different functions in humoral immunity. However, IL-6 and IL-21 are not functionally redundant in the conventional sense; they may share signaling pathways, but they act at different times and on different cells during the response. During acute infection, IL-6 is produced by APCs, including B cells, as we show here. IL-6 acts on CD4^+^ T cells to initiate or reinforce their polarization toward T~FH~ cells. IL-21 acts later on T~FH~ polarized cells in an autocrine manner, through a positive feedback loop to reinforce T~FH~ commitment ([@bib76]), and on GC B cells to drive their differentiation. Finally, IL-6 and IL-21 are not the only cytokines initiating TD B cell immunity, as IL-4 and IL-27, another Stat3 signaling cytokine, have recently been implicated in T~FH~ cell differentiation and GC responses ([@bib5]; [@bib77]), and IL-12 has also been shown to be important in T~FH~ development in humans ([@bib49]).

A role for B cell--derived IL-6 in GC and T~FH~ responses
---------------------------------------------------------

We found that activated WT B cells can stimulate *Il21* expression in CD4^+^ T cells in vitro and that IL-6 was necessary and sufficient for this effect. We also performed a detailed kinetic analysis of IL-6 and IL-21 expression in vivo and found that IL-6 was produced from B cells and myeloid cells in a transient fashion, peaking on day 2 to 3 after infection, then dropping over subsequent days. Although *Il6* was expressed in myeloid cells isolated from influenza-infected mice, we found that viral antigens induced high *Il6* expression in activated follicular B cells within the draining LN, by far the most abundant APC in the tissue at that time. Conversely, *Il21* expression was restricted to CD4^+^ T cells, increasing from days 3 to 10. We therefore reasoned that IL-6 could play a critical early role in the GC response. Indeed, we were able to improve the weak T~FH~ cell response of IL-6/IL-21 doubly deficient mice and the GC response through the provision of naive WT B cells to the animals just before infection. These data collectively support a role for paracrine secretion of IL-6 by B cells to CD4^+^ T cells as an important early step in T~FH~ development or expansion. More recently, IL-6 was shown to play an essential late role in the clearance of a chronic viral infection, with follicular DCs supplying IL-6 to T~FH~, to drive GC formation and neutralizing antibody production ([@bib35]). Collectively, these studies point to a need for provision of IL-6 both early and late for optimal TD antibody responses but suggest that the preferred cellular source of IL-6 changes as the response progresses and T~FH~ cells interact with different cellular partners.

B cells require Oct2 and OBF-1 to produce IL-6
----------------------------------------------

There is accumulating evidence for the direct role of these two transcription factors in the cytokine-mediated regulation of antibody responses ([@bib20]; [@bib27]). Here we found that *Il6* expression in B cells is dependent on Oct2 and OBF-1. We identified four consensus sites in the *Il6* gene to which Oct2 bound in vitro and in vivo. It is known that OBF-1 is recruited, in an Oct factor--dependent way, to such consensus sequences ([@bib14]; [@bib34]; [@bib71]). Therefore, we propose that in activated B cells, OBF-1 is able to bind with Oct2 to the consensus sites in the murine *Il6* locus, activating the gene. This was specific to B cells, as IL-6 production was not affected in macrophages or DCs isolated from *Obf-1^−/−^* or *Oct2^−/−^* mice ([Fig. 4](#fig4){ref-type="fig"} and not depicted). Consequently, both OBF-1-- and Oct2-deficient B cells were weak in vitro inducers of *Il21* expression in CD4^+^ T cells.

OBF-1 is essential for the formation of GC B cells ([@bib69]). However, the specific requirements for OBF-1 in the GCs are not fully understood. Impaired BCR signaling in *OBF-1^−/−^* B cells ([@bib62]; [@bib65]), possibly mediated through loss of *SpiB* expression ([@bib4]), is likely to be the dominant disability blocking GC development. Clearly, poor IL-6 production by B cells is not the sole defect underlying the total lack of GCs in *Obf-1^−/−^* mice, as *Il6^−/−^* and *Oct2^−/−^* mice can make GCs normally ([Figs. 1](#fig1){ref-type="fig"} and [6](#fig6){ref-type="fig"}). Here we observed a significant reduction of T~FH~ cells in the draining LNs of influenza-infected OBF-1--deficient mice. As OBF-1 is expressed in activated T cells ([@bib67]; [@bib89]) and regulates essential T helper cytokines ([@bib11]), it was possible that T~FH~ cells required OBF-1 intrinsically for their differentiation. However, analysis of mixed BM chimeras excluded a T cell--intrinsic role for OBF-1 in T~FH~ formation. Conversely, WT T cells were impaired in their differentiation to T~FH~ when *Obf-1^−/−^* B cells were present, indicating that the observed T~FH~ and GC phenotypes in OBF-1--deficient mice are both B cell intrinsic.

A temporal model of T~FH~ and GC generation
-------------------------------------------

Bcl6 is the signature transcriptional regulator of both T~FH~ and GC B cells, and Bcl6 reporter mice have recently revealed the in vivo dynamics of development of these cells during immune responses ([@bib6]; [@bib42]). Upon infection or immunization, antigen-presenting DCs prime CD4 T cells to rapidly but modestly induce *Bcl6* expression and to initiate T~FH~ cell differentiation. However, this signal provokes only incomplete T~FH~ cell differentiation, as the nascent T~FH~ cells do not express PD-1 or CXCR5 and cannot sustain *Bcl6* expression or GC development. A second, stronger wave of *Bcl6* expression in CD4^+^ cells, induced through contact with B cells, correlates with increased cell division and CXCR5 and PD-1 expression. These studies confirm that DCs are important for early T~FH~ priming but that from approximately day 3.5 onwards, well before GCs are formed, B cells are required to sustain and reinforce *Bcl6* expression and T~FH~ expansion and to enable follicular entry ([@bib36]; [@bib86]; [@bib23]; [@bib6]; [@bib33]). In this paper, we demonstrate an important interplay between IL-6 and IL-21 in the formation of T~FH~ and GCs. The kinetics of production and cellular sources of IL-6 and IL-21 documented here during acute viral infection are consistent with these factors being part of the critical communication between B cells and T~FH~ that is required for GC formation.

Because IL-6 and IL-21 both signal through Stat3 ([@bib87]; [@bib53]; [@bib26]), it is possible that precursors of T~FH~ need to exceed a certain Stat3 signaling threshold or signal duration to efficiently up-regulate and maintain the high *Bcl6* levels required to commit fully to differentiation. Loss of one cytokine might be tolerated, but loss of both could drop the signal below this limit. Thus, IL-6 and IL-21 may cooperate to ensure that T~H~ cells receive a sufficiently strong and durable signal to mature, enter the follicle, and support GC formation for a potent antibody response.

MATERIALS AND METHODS
=====================

### Mice, immunization, and tissue recovery.

All mutant mice were \>10 generations backcrossed onto the C57BL/6 background. IL-6--deficient ([@bib44]), IL-21--deficient ([@bib58]), IL-21R--deficient ([@bib56]), IL-21--GFP reporter ([@bib48]), Ly5.1 C57BL/6, recombination activating gene 1--deficient (*Rag-1^−/−^*; [@bib74]), CD19-deficient ([@bib28]), Oct2-deficient ([@bib18]) and OBF-1--deficient ([@bib69]) mice were bred and maintained in the specific pathogen--free facilities of the Walter and Eliza Hall Institute of Medical Research. The *Oct2^+/+^* and *Oct2^−/−^* mice used here were *Rag1^−/−^* mice reconstituted with fetal liver cells, as the *Oct2* mutation is lethal when homozygous ([@bib18]). TCR-α--deficient mice ([@bib59]) were maintained at the University of Melbourne. Reconstitution experiments used donor BM from *TCRα^−/−^*, *Cd19^−/−^*, *Obf-1^−/−^*, and C57BL/6 strains, mixed in equal ratios and injected into *Rag-1^−/−^* mice. At the indicated times after infections, mice were sacrificed, spleens and mLNs were removed, and single cell suspensions were prepared for analysis as previously described ([@bib9]). All procedures were approved by the Animal Ethics Committee of the Walter and Eliza Hall Institute of Medical Research.

### Viral infections.

Mice were inoculated intranasally with 10^4^ pfu of the HKx31 (H3N2) influenza virus ([@bib31]; [@bib7]). Virus stocks were grown in the allantoic cavity of 10 d embryonated hen's eggs and stored in aliquots at −80°C.

### Antibodies and flow cytometry.

Single cell suspensions of BM cells, splenocytes, or LNs were stained with fluorochrome or biotin-labeled antibodies. Cells were analyzed on an LSRII, FACSCalibur, or FACSCanto cytometer (BD) or were sorted using a MoFlo (Beckman Coulter) or FACSAria (BD) using a live lymphocyte gate (defined as negative for propidium iodide uptake). Data were analyzed with FlowJo (Tree Star) and Prism (GraphPad Software) software. Antibodies used were the following: α-CD4 (GK1.5; FITC; BD), α--PD-1 (RPMI-30; PE; BioLegend), α-CXCR5 (2G8; bio; BD), α-B220/CD45R (RA3-6B2; APC; BD), α-FAS/CD95 (DX2; PE; BD), CD86 (GL1; PE; BD), CD69 (H1.2F3; biotin; BD), PNA (FITC; Vector Laboratories), α-CD8 (53-67; FITC; BD), α-CD44 (IM7; APC; BD), α-KLRG1 (2F1; PECy7; BD), D^b^NP~366~ tetramer (PE; in house), D^b^PA~224~ tetramer (PE; in house), α-CD19 (ID3; APC; BD), α-IgM (331-12; ITC; in house), α-IgD (112GC; PE; in house), α-CD11c (H13; PE; BD), and α-Mac1/CD11b (M1/70; FITC; BD).

### Immunofluorescence histology.

Splenic tissue samples were fixed in 4% paraformaldehyde. 7-µm sections were cut and stained with α-B220 (RA3-6B2; biotin; BD), α-CD3 (rabbit polyclonal; Thermo Fisher Scientific), and α-GL7 (supernatant; in house). Secondary antibodies used were streptavidin-Cy5 (BD), α--rabbit Ig Alexa Fluor 488 (goat polyclonal; Invitrogen), and α--rat Ig Alexa Fluor 555 (goat; Invitrogen). Multiple images from spleen sections were taken with an LSM 5 life microscope (Carl Zeiss), using the Mosaic module (Carl Zeiss) to stitch and align all images taken from one section. For analysis, images covering 1/4 to 1/2 of a spleen section were taken and processed from each sample. The images were analyzed and quantified with the AxioVision (Carl Zeiss) software.

### Virus-specific ELISA.

Influenza-specific antibody titers were determined by ELISA ([@bib66]) using 96-well plates coated with 0.25 mg/well of purified, detergent-disrupted influenza HKx31. In brief, purified HKx31 influenza virus was disrupted in a 1/10 dilution of lysis buffer (0.05 M Tris, pH 7.5, 0.5% Triton X-100, and 0.6 M KCI) in PBS, pH 7.2. Protein concentration of HKx31 virus antigen was determined by Bradford assay. Bound antibody was detected with HRP (horseradish peroxidase)-conjugated goat α--mouse antibodies specific for IgM and HRP-conjugated rabbit α--mouse total IgG (SouthernBiotech) and visualized with ABTS substrate (2,2'-Azinobis (3-ethylbenzthiazoline Sulfonic Acid) Diammonium salt; A-1888; Sigma-Aldrich). Titers shown in [Fig. 2](#fig2){ref-type="fig"} are those that gave 50% of the maximal response.

### Cell preparation and culture.

Cells were cultured in RPMI 1640 supplemented with 10% fetal calf serum, 2 mM glutamine, 100 mg/ml penicillin, 100 mg/ml streptomycin, and 50 µM 2-mercaptoethanol. Follicular B cells, DCs, and macrophages from the mLNs were isolated by cell sorting using α-CD19, α-CD11c, and α-Mac1 antibodies. Splenic B cells or B cells from the LNs were isolated using α-CD45R/B220- or α-CD19--coupled magnetic beads (Miltenyi Biotec).

For the preparation of BM-derived macrophages, BM was harvested from the femurs of 8--12-wk-old mice and cultured in bacterial-grade dishes for 6 d in RPMI medium supplemented with 10 ng/ml recombinant murine GM-CSF (PeproTech). On days 3 and 5 of the culture period, 70% of the culture supernatant containing nonadherent cells was removed and replaced with fresh media containing 10 ng/ml GM-CSF. On day 6, the loosely adherent and nonadherent cells were removed by vigorous washing. The remaining adherent macrophage population was harvested by incubating the cells for 5 min in PBS + 10 mM EDTA followed by gentle scraping with a rubber policeman (SARSTEDT).

For DC culture, BM cells were extracted and erythrocytes were removed by brief exposure to 0.168 M NH~4~Cl. Cells were cultured for 5 d at a density of 1.5 × 10^6^ cells/ml in RPMI 1640 medium containing 100 ng/ml mouse Flt3L (PeproTech) at 37°C in 10% CO~2~ ([@bib51]).

Splenic B cells, BM-derived macrophages, and BM-derived DCs were culture for 24--48 h in RPMI 1640. The cell cultures were stimulated with the following mitogens as indicated: 10 µg/ml LPS from *Escherichia coli* 0111:4B (Sigma-Aldrich), 1 µM oligonucleotide CpG 1668 (sequence 5′-TCCATGACGTTCCTGATGCT-3′, fully phosphothioated; GeneWorks). Anti-µ and anti-CD40 were used at 10 µg/ml as described previously ([@bib17]).

For the T cell cultures, naive splenic CD4^+^CD62L^+^ T cells were isolated using α-CD4 FITC (GK1.5) and an α-FITC Multisort kit followed by α-CD62L--coupled magnetic beads (Miltenyi Biotech). Isolated naive T cells were cultured for 5 d in RPMI 1640 medium on plates coated with both 10 µg/ml α-CD3 (45-2C11) and in the presence of monoclonal 2 µg/ml α-CD28 (37.51), together with recombinant IL-6 (10% vol/vol, prepared in house) and 100 ng/ml recombinant IL-21 (PeproTech).

For B/T cell co-cultures, splenic B cells were isolated using α-CD19 or α-B220 beads (Miltenyi Biotech) and stimulated for 24 h with CpG as described above. Activated B cells were washed three times with PBS and co-cultured in different ratios ([Fig. 3](#fig3){ref-type="fig"}: 3 × 10^5^ or 3 × 10^3^ B cells to 3 × 10^5^ T cells; [Fig. 4](#fig4){ref-type="fig"}: 2 × 10^5^ or 6 × 10^4^ B cells to 6 × 10^5^ T cells) with naive C57BL/6 T cells in the conditions described above. After 5 d, the CD4^+^ cells were recovered by flow cytometric cell sorting.

### B cell rescue.

1--2 × 10^7^ splenic B cells were isolated from Ly5.1 congenic mice and injected i.v. on two subsequent days into C57BL/6 and IL-6/IL-21 DKO mice. On the third day, the host mice were infected with HKx31 influenza virus. Mice were sacrificed 10 d after infection, and GCs and T~FH~ cells in mLNs were analyzed by flow cytometry. To adjust for technical variation between experiments that was not related to genotype, the percentages of T~FH~ cells (of total CD4^+^ T cells) or GC B cells (of B220^+^ B cells) were normalized to the mean frequency of the WT control from each experimental cohort. We were thus able to determine the fold change of T~FH~ or GC B cell percentage compared with each control group. We also compared T~FH~ and GC B cell data from the transplanted mice with data from infected C57BL/6 and DKO mice that had not received B cells.

### Western blotting.

OBF-1 and Oct2 expression was detected using our monoclonal rat α--mouse antibodies (clone 9A2, [@bib19]; clone 6E4, [@bib20]). Protein extracts corresponding to equal cell numbers were loaded onto the gel, with equal protein loading confirmed with Ponceau red stains of the membrane after protein transfer. A goat α-actin antiserum (Santa Cruz Biotechnology, Inc.) was used as a loading control.

### Quantitative RT-PCR.

First-strand cDNA was transcribed (SuperScript III First-Strand Synthesis System; Invitrogen) from total RNA (RNeasy Micro kit; QIAGEN) using the manufacturers' protocols. Real-time qPCR analysis was performed using a SYBR green system (Superarray), according to the manufacturer's instructions. The expression data were analyzed on a sequence detection system (ABI Prism 7900HT; Applied Biosystems) and CFX384 real-time system (Bio-Rad Laboratories) using relative quantification of gene expression. Expression was normalized using *hydroxymethylbilane synthase* (*Hmbs*) as a housekeeping gene. Normalization of expression data was computed by the qGENE tool ([@bib72]).

Primers used for cDNA amplification were as follows: *Hmbs*, (forward) 5′-GACCTGGTTGTTCACTCCCTGAAG-3′ and (reverse) 5′-GACAACAGCATCACAAGGGTTTTC-3′; *Bcl6*, (forward) 5′-GCCGGCTCAATAATCTCGTGAACAGGTCC-3′ and (reverse) 5′-CCAGCAGTATGGAGGCACATCTCTGTATGC-3′; *Il21*, (forward) 5′-TCAGCTCCACAAGATGTAAAGGG-3′ and (reverse) 5′-GGGCCACGAGGTCAATGAT-3′; and *Il6*, the QuantiTect Primer Assay for Mm_IL6 (QIAGEN).

### EMSA.

Nuclear extracts were prepared ([@bib68]) and EMSA was performed as previously described ([@bib19]). Restriction fragment probes were labeled using \[^32^P\]dATP and Klenow DNA polymerase. Probes for *Il6* locus were generated through PCR amplification using genomic C57BL/6 DNA as a template. 130-bp- to 350-bp-long PCR products were subsequently labeled using \[^32^P\]dATP and Klenow DNA polymerase.

Primer sequences for probes of *Il6* locus are as follows: IL-6--P1, (forward) 5′-GGATACAATCAGCCCCATAC-3′ and (reverse) 5′-GTATGGGGCTGATTGTATCC-3′; IL-6--P2, (forward) 5′-ATCAACCGGCTTTTCATTTTA-3′ and (reverse) 5′-TGCTCCCATGTTTAATAGTTCAA-3′; IL-6--P3, (forward) 5′-CCAGTTGGAACATCTTCTGCG-3′ and (reverse) 5′-TGGGGTACAAAGCTAAACAAA-3′; and IL-6--P4, (forward) 5′-AGGTGAAATCTCAGGGTAGT-3′ and (reverse) 5′-TAAAACATGGGGTACAGAGT-3′.

### ChIP.

ChIP was performed essentially as described previously ([@bib27]) except that Protein G Dynabeads (Invitrogen) were used to capture the protein--DNA immune complexes. The primers used to amplify the four putative Oct2-binding sites in the *Il6* gene are listed in the previous section, and the *Cd36* primers have been described previously ([@bib27]).
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